SCAREASE Trademark

Trademark Overview


On Wednesday, October 30, 2024, a trademark application was filed for SCAREASE with the United States Patent and Trademark Office. The USPTO has given the SCAREASE trademark a serial number of 98828999. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, June 6, 2025. This trademark is owned by Clozex Medical, Inc.. The SCAREASE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for wound healing and scar therapy
scarease

General Information


Serial Number98828999
Word MarkSCAREASE
Filing DateWednesday, October 30, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, June 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices for wound healing and scar therapy

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 30, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClozex Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFranklin, MA 02038

Trademark Events


Event DateEvent Description
Wednesday, October 30, 2024NEW APPLICATION ENTERED
Saturday, April 26, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 30, 2025ASSIGNED TO EXAMINER
Wednesday, April 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 30, 2025NON-FINAL ACTION E-MAILED
Friday, June 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 30, 2025NON-FINAL ACTION WRITTEN